Summit Therapeutics SMMT
NASDAQ SMMT
$16.40 +0.92 (+5.94%)
As of: Sep 29, 2026 · 3:59 PM EDT

Summit Therapeutics (SMMT) Receivables - Other (2017 - 2025)

Updated

Summit Therapeutics' Receivables - Other came in at $12,000 for Q1 2025.

Analysis

Summit Therapeutics (SMMT) Receivables - Other (2017 - 2025) Analysis & Trends

At the end of FY2021, Summit Therapeutics' Receivables - Other was $574,000.

  • Receivables - Other carries a four-year compound annual growth rate of 5.8% (FY2017 to FY2021).
  • Going back by year, Receivables - Other was $1.16 million in FY2019, $5.11 million in FY2018 and $457,902 in FY2017.
  • The Q1 2025 figure represents the lowest quarterly Receivables - Other in data going back to Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Summit Therapeutics 12.28 Bn 10.04 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 12,000.00
Sep 30, 2024 90,000.00
Jun 30, 2024 48,000.00
Jun 30, 2022 1.11 Mn
Mar 31, 2022 555,000.00
Dec 31, 2021 574,000.00
Dec 31, 2019 1.16 Mn
Jan 31, 2019 4.86 Mn
Jan 31, 2018 4.85 Mn
Jan 31, 2017 424,487.70
API Access

Summit Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=SMMT&period=max&api_key=YOUR_API_KEY